By Jaspreet Singh (Reuters) – Elon Musk-owned social media platform X is poised for the company’s first year of advertising revenue growth since its acquisition
Category: Business
China, US need to cooperate in AI, says US-China relations committee head
BEIJING (Reuters) – China and the United States need to cooperate in artificial intelligence, and duplication of efforts in the area could be avoided, the
Apple is welcome to expand investment in China, commerce minister tells CEO
BEIJING (Reuters) – China’s commerce minister told Apple CEO Tim Cook on Monday that the company is welcome to expand investment in the country, a
Tesla jumps as possible tariff leeway, lower share price draw investors
By Deborah Mary Sophia and Akash Sriram (Reuters) -Tesla shares surged 9% on Monday after this year’s steep decline following reports the Trump administration is
Apple losing over $1 billion a year on streaming service, the Information reports
(Reuters) -Apple is losing more than $1 billion a year on its streaming service, the Information reported on Thursday, citing two people familiar with the
Nvidia-backed CoreWeave targets up to $32 billion valuation in test for AI IPOs
By Manya Saini and Niket Nishant (Reuters) -CoreWeave is targeting a valuation of up to $32 billion on a fully diluted basis in its U.S.
Nvidia CEO says orders for 3.6 million Blackwell GPUs exclude Meta
(Reuters) -Nvidia CEO Jensen Huang said on Wednesday that orders for some 3.6 million of its flagship “Blackwell” chips from four top cloud service providers
General Mills forecasts hit to annual sales, profit as snacking demand slows
By Neil J Kanatt (Reuters) -General Mills cut its annual sales and profit forecasts on Wednesday, as the Pillsbury owner takes a hit from choppy
Adobe rolls out AI agents for online marketing tools
By Stephen Nellis SAN FRANCISCO (Reuters) – Adobe on Tuesday said it is rolling out artificial intelligence “agents” that brands can use to help consumers
Factbox-Widely used drugs on US imports list from Europe
(Reuters) – Widely used prescription medicines could get caught up in the Trump administration’s tariff trade wars and EU retaliation. The following is a list